1. Home
  2. FTF vs FHTX Comparison

FTF vs FHTX Comparison

Compare FTF & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Limited Duration Income Trust of Beneficial Interest

FTF

Franklin Limited Duration Income Trust of Beneficial Interest

N/A

Current Price

$5.37

Market Cap

216.2M

Sector

Finance

ML Signal

N/A

Logo Foghorn Therapeutics Inc.

FHTX

Foghorn Therapeutics Inc.

N/A

Current Price

$2.01

Market Cap

173.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FTF
FHTX
Founded
N/A
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
216.2M
173.4M
IPO Year
2003
2020

Fundamental Metrics

Financial Performance
Metric
FTF
FHTX
Price
$5.37
$2.01
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
★ $6.00
AVG Volume (30 Days)
255.8K
★ 1.1M
Earning Date
01-01-0001
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 25.32
EPS
★ N/A
N/A
Revenue
N/A
★ $30,909,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$15.98
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 36.75
52 Week Low
$5.30
$1.79
52 Week High
$6.39
$7.61

Technical Indicators

Market Signals
Indicator
FTF
FHTX
Relative Strength Index (RSI) 37.45 17.15
Support Level N/A $1.79
Resistance Level $5.90 $5.35
Average True Range (ATR) 0.08 0.29
MACD 0.00 -0.10
Stochastic Oscillator 22.89 9.68

Price Performance

Historical Comparison
FTF
FHTX

About FTF Franklin Limited Duration Income Trust of Beneficial Interest

Franklin Limited Duration Income Trust is a closed-end investment company based in the United States. It conducts its investment to provide high, current income, with a secondary objective of capital appreciation. To align with its investment objective, is to invest in a diversified mix of fixed-income securities. Its portfolio is dominated by considerable investments in high-yield corporate bonds while touching upon other avenues such as senior secured floating rate corporate loans, mortgage-backed securities, commercial mortgage-backed securities, asset-backed securities, common stocks, and other short-term investments.

About FHTX Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.

Share on Social Networks: